BIO-FD&C Co.,Ltd. (KOSDAQ:251120)

Market Cap	115.22B
Revenue (ttm)	16.07B
Net Income (ttm)	4.50B
Shares Out	8.70M
EPS (ttm)	528.00
PE Ratio	25.09
Forward PE	14.29
Dividend	n/a
Ex-Dividend Date	n/a

Volume	21,198
Average Volume	17,002
Open	13,930
Previous Close	13,930
Day's Range	13,590 - 14,030
52-Week Range	12,410 - 19,150
Beta	0.58
RSI	37.80
Earnings Date	n/a

About BIO-FD&C

BIO-FD&C Co.,Ltd. develops active ingredients for anti-aging cosmetics in South Korea. It offers plant cell, peptide, herbal extract, and biomolecule products for wrinkle improvement/skin regeneration, skin brightening, skin moisturizing, anti-inflammation/skin soothing, and anti-oxidation. The company was founded in 2005 and is headquartered in Incheon, South Korea.

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2005
• Country: South Korea
• Stock Exchange: KOSDAQ
• Ticker Symbol: 251120

Financial Performance

In 2023, BIO-FD&C's revenue was 15.59 billion, a decrease of -1.66% compared to the previous year's 15.86 billion. Earnings were 5.59 billion, an increase of 28.83%.